EC Healthcare 미래 성장

Future 기준 확인 4/6

EC Healthcare은 연간 수입과 매출이 각각 151.5%와 8.7% 증가할 것으로 예상되고 EPS는 연간 113.8%만큼 증가할 것으로 예상됩니다.

주요 정보

151.5%

수익 성장률

113.8%

EPS 성장률

Consumer Services 수익 성장	22.8%
매출 성장률	8.7%
향후 자기자본 수익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	04 Nov 2024

최근 미래 성장 업데이트

Recent updates

EC Healthcare (HKG:2138) Shares Fly 29% But Investors Aren't Buying For Growth

Dec 18

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Nov 13

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

Sep 05

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Jul 26

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

Dec 24

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

Dec 08

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

Dec 01

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Sep 15

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Aug 24

Is EC Healthcare (HKG:2138) Using Too Much Debt?

Aug 10

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Jul 14

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Jun 26

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

Jun 15

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

May 12

Is EC Healthcare (HKG:2138) Potentially Undervalued?

Mar 08

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Feb 03

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Dec 20

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Oct 25

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Sep 20

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Sep 01

EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 28

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Jul 14

EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042

Jun 26

When Should You Buy EC Healthcare (HKG:2138)?

May 26

EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around

Apr 18

Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?

Feb 24

수익 및 매출 성장 예측

SEHK:2138 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (HKD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2026	4,749	17	N/A	N/A	1
3/31/2025	4,443	7	N/A	N/A	1
9/30/2024	4,153	-12	N/A	N/A	N/A
6/30/2024	4,182	-15	N/A	N/A	N/A
3/31/2024	4,211	-19	528	689	N/A
12/31/2023	4,157	-11	422	709	N/A
9/30/2023	4,104	-4	317	729	N/A
6/30/2023	3,989	33	255	667	N/A
3/31/2023	3,875	70	193	605	N/A
12/31/2022	3,622	93	162	499	N/A
9/30/2022	3,369	117	132	392	N/A
6/30/2022	3,144	157	240	500	N/A
3/31/2022	2,920	198	348	608	N/A
12/31/2021	2,823	253	479	684	N/A
9/30/2021	2,727	309	610	760	N/A
6/30/2021	2,404	251	541	690	N/A
3/31/2021	2,080	193	472	621	N/A
12/31/2020	1,854	163	487	597	N/A
9/30/2020	1,627	133	503	573	N/A
6/30/2020	1,788	210	505	574	N/A
3/31/2020	1,949	287	507	576	N/A
12/31/2019	2,023	325	273	452	N/A
9/30/2019	2,098	364	40	327	N/A
6/30/2019	1,975	363	-5	283	N/A
3/31/2019	1,852	361	-49	238	N/A
12/31/2018	1,715	355	108	278	N/A
9/30/2018	1,578	348	265	317	N/A
6/30/2018	1,450	314	N/A	320	N/A
3/31/2018	1,322	279	N/A	324	N/A
12/31/2017	1,253	266	N/A	302	N/A
9/30/2017	1,183	253	N/A	280	N/A
6/30/2017	1,079	227	N/A	230	N/A
3/31/2017	975	201	N/A	180	N/A
12/31/2016	878	170	N/A	123	N/A
9/30/2016	780	139	N/A	66	N/A
6/30/2016	744	144	N/A	71	N/A
3/31/2016	708	149	N/A	76	N/A
12/31/2015	688	166	N/A	105	N/A
9/30/2015	668	183	N/A	134	N/A
6/30/2015	645	179	N/A	146	N/A
3/31/2015	621	174	N/A	159	N/A
3/31/2014	490	81	N/A	145	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 2138 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.3% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: 2138 (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: 2138 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: 2138 의 수익(연간 8.7% ) Hong Kong 시장( 7.8% 보다 빠르게 성장할 것으로 예상됩니다. 7.8% 연간).

고성장 수익: 2138 의 수익(연간 8.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 2138 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/23 20:04
장 마감 주가	2024/12/23 00:00
수익	2024/09/30
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

EC Healthcare 10 애널리스트 중 1 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Tingting Li	BOCI Research Ltd.
Zhuonan Xu	China International Capital Corporation Limited
null null	China International Capital Corporation Limited

EC Healthcare 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024

Price target increased by 35% to HK$2.84

EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024

Price target decreased by 15% to HK$5.22

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

Consensus EPS estimates fall by 31%

Recent updates

Upcoming dividend of HK$0.01 per share

EC Healthcare (HKG:2138) Shares Fly 29% But Investors Aren't Buying For Growth

Dividend of HK$0.01 announced

First half 2025 earnings released: EPS: HK$0.012 (vs HK$0.006 in 1H 2024)

EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025

New minor risk - Market cap size

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024

Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024

Price target increased by 35% to HK$2.84

Less than half of directors are independent

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024

An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.

EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement

When Should You Buy EC Healthcare (HKG:2138)?

Is EC Healthcare (HKG:2138) A Risky Investment?

New minor risk - Share price stability

EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million.

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

Price target decreased by 15% to HK$5.22

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

EC Healthcare Announces Executive Changes

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023

Upcoming dividend of HK$0.042 per share at 2.6% yield

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023

Is EC Healthcare (HKG:2138) Using Too Much Debt?

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Consensus EPS estimates fall by 31%

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Price target decreased by 11% to HK$8.03

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare, Annual General Meeting, Aug 23, 2023

EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

Is EC Healthcare (HKG:2138) Potentially Undervalued?

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Price target increased to HK$9.33

Price target increased to HK$8.04

Upcoming dividend of HK$0.058 per share

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Investor sentiment improved over the past week

Consensus forecasts updated

First half 2023 earnings released

EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023

Price target decreased to HK$8.89

Less than half of directors are independent

EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022

EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022

Investor sentiment improved over the past week

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Price target decreased to HK$10.17